---
title: "ZBD: Ha ZBD received the approval notice for the drug supplement application"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/235163410.md"
description: "ZBD announced that its wholly-owned subsidiary Harbin Zhenbao Pharmaceutical Co., Ltd. has received the \"Drug Supplement Application Approval Notice\" issued by the National Medical Products Administration. The notice approves the change of the marketing authorization holders for 10 drugs, including Olanzapine Tablets, Apixaban Tablets, Escitalopram Oxalate Tablets, Desloratadine Tablets, Voriconazole Tablets, Mecobalamin Tablets, Rivaroxaban Tablets, Valsartan Tablets, and Donepezil Hydrochloride Tablets, from Anhui Jiuzhou Fangyuan Pharmaceutical Co., Ltd. to Harbin Zhenbao Pharmaceutical Co., Ltd. The above matters will not have a significant impact on the company's current operating performance"
datetime: "2025-04-09T07:46:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/235163410.md)
  - [en](https://longbridge.com/en/news/235163410.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/235163410.md)
generator: "portal-rs"
---

# ZBD: Ha ZBD received the approval notice for the drug supplement application

ZBD announced that its wholly-owned subsidiary Harbin Zhenbao Pharmaceutical Co., Ltd. has received the "Drug Supplement Application Approval Notice" issued by the National Medical Products Administration. The notice approves the change of the marketing authorization holders for 10 drugs, including Olanzapine Tablets, Apixaban Tablets, Escitalopram Oxalate Tablets, Desloratadine Tablets, Voriconazole Tablets, Mecobalamin Tablets, Rivaroxaban Tablets, Valsartan Tablets, and Donepezil Hydrochloride Tablets, from Anhui Jiuzhou Fangyuan Pharmaceutical Co., Ltd. to Harbin Zhenbao Pharmaceutical Co., Ltd. The above matters will not have a significant impact on the company's current operating performance

### Related Stocks

- [603567.CN](https://longbridge.com/en/quote/603567.CN.md)

## Related News & Research

- [TECHNICALS-New York coffee may bounce further toward $3.1955](https://longbridge.com/en/news/297622754.md)
- [The election campaign to replace Macron in France is heating up as the summer vacation season ends](https://longbridge.com/en/news/297631495.md)
- [Denmark sends conscripts to Greenland as Arctic tensions grow](https://longbridge.com/en/news/297744144.md)
- [Elders flags spring 2026 cattle prices easing as restocker demand cools](https://longbridge.com/en/news/297560887.md)
- [TECHNICALS-CBOT wheat may retest support at $7.54-3/4](https://longbridge.com/en/news/297752187.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**